Home > Clinical Resources > Liver > Liver Guidance

Liver Guidance

Guidance

First published on 20 Nov 2018

Alcohol care teams: reducing acute hospital admissions and improving quality of care

Quality and Productivity: Proven Case Study Alcohol care teams: reducing acute hospital admissions and improving quality of care Provided by: The British Society of Gastroenterology and Bolton NHS Foundation Trust Publication type: Quality and productivity example Sharing good practice: What […]

Guidance

First published on 20 Nov 2018

Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources

Executive Summary Alcohol misuse and alcohol‐related problems, especially binge drinking and alcohol-related liver disease, are major public health concerns. Recently, much attention has focused on social policy and measures to reduce drinking. There is an additional need to provide care […]

Guidance

First published on 05 Apr 2018

Caution about the use of ulipristal acetate (Esmya)

Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]

Guidance

First published on 21 Feb 2018

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Guidance

First published on 01 Feb 2016

Treatment Recommendations for the management of patients with chronic HCV Infection

These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]

Guidance

First published on 25 Nov 2015

NICE guidance on Daclatasvir for treating chronic hepatitis C

NICE technology appraisal guidance [TA364] Published date: November 2015

Guidance

First published on 25 Nov 2015

NICE guidance on Ledipasvir–Sofosbuvir for treating chronic hepatitis C

Guidance

First published on 25 Oct 2015

NICE guidance on Ombitasvir–Paritaprevir–Ritonavir with or without Dasabuvir for treating chronic hepatitis C

NICE technology appraisal guidance [TA365] Published date: November 2015

Guidance

First published on 22 Oct 2015

NHS England service specification for Operational Delivery Networks for hepatitis C care in adults

22nd October 2015 NHS England has published the service specification for Operational Delivery Networks (ODNs) for hepatitis C care in adults. The full document is available below. Many BSG members will have been involved in the set up processes to date […]